OpenAlex
PricingAboutJobs
Log inGet started
Work

Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma

HTML

Year: 2022
Type: letter
Source: The Lancet Oncology
DOI: 10.1016/s1470-2045(22)00547-2
Authors: Osman Sütcüoğlu, Ahmet Özet, Ozan Yazıcı, Nuriye Özdemir
Institution: Gazi University
Language: English

Topic: Sarcoma Diagnosis and Treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: doxorubicin, trabectedin, leiomyosarcoma, metastatic sarcoma, unresectable sarcoma, combination chemotherapy, progression-free survival, trial interpretation
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W4297103012
Cites: 5
Cited by: 2
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security